United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

b.braun medical ltd - etomidate - emulsion for injection - 2mg/1ml

United States - English - NLM (National Library of Medicine)

western chemical inc. - metomidate (unii: z18zyl8y51) (metomidate - unii:z18zyl8y51) - metomidate 1000 mg in 1 g - indication:   for the sedation and anesthesia of ornamental finfish. aquacalmtm is not for use in fish intended for human or animal consumption. sedation may be necessary in situations such as strip spawning for hatchery rearing, transporting fish from supplier to wholesaler or retailer, photographing fish as part of a strategic marketing approach, or removal of fish from exhibit tanks prior to cleaning. anesthesia may be necessary in situations where detailed fish examination or minor surgical procedures are to be conducted.

Malta - English - Medicines Authority

p & d pharmaceuticals limited - etomidate 2 mg/ml - solution for injection

Zimbabwe - English - Medicines Control Authority

piramal critical care south africa (pty) ltd - etomidate - injectable; injection - 2mg/ml

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - solution for injection - etomidate 2 mg/ml - anesthetics

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen pharmaceutica - etomidate - withdrawn form - 2 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen pharmaceutica - etomidate - 125 milligram

Namibia - English - Namibia Medicines Regulatory Council

janssen pharmaceutica (pty) ltd - etomidate 20 mg/10ml - injectable solution - injection

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - emulsion for injection - etomidate 2 mg/ml - anesthetics

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - etomidate (unii: z22628b598) (etomidate - unii:z22628b598) - amidate is indicated by intravenous injection for the induction of general anesthesia. when considering use of amidate, the usefulness of its hemodynamic properties (see clinical pharmacology) should be weighed against the high frequency of transient skeletal muscle movements (see adverse reactions). intravenous amidate is also indicated for the supplementation of subpotent anesthetic agents, such as nitrous oxide in oxygen, during maintenance of anesthesia for short operative procedures such as dilation and curettage or cervical conization. amidate is contraindicated in patients who have shown hypersensitivity to it.